Synopsis of recent research by authors named "Shu-Hua Wu"
- Shu-Hua Wu's recent research primarily focuses on the efficacy and mechanisms of novel therapeutic agents for cancer and viral infections, with a particular emphasis on colorectal cancer and COVID-19 treatments.
- Key findings include the demonstration of RAY1216's antiviral effects in COVID-19 patients and the potential of midostaurin to enhance anti-PD-1 immunotherapy in colon cancer by modulating the tumor microenvironment.
- Additional studies have elucidated roles of specific molecular pathways in cancer resistance, such as the involvement of atypical chemokine receptor 3 in tumorigenesis and mechanisms underlying 5-fluorouracil resistance in colorectal cancer.